Corporate

  • June 04, 2026

    Meta Says 9th Circ. Needn't Revisit Facebook Genocide Ruling

    Meta Platforms Inc. is fighting a petition from two women asking the Ninth Circuit for a full court rehearing of their suit alleging that Facebook's 2009 algorithms contributed to the destruction of their villages during the genocide of Rohingya Muslims in Myanmar, saying the circuit's interpretation of Section 230 of the Communications Decency Act doesn't need revisiting.

  • June 04, 2026

    'Parallel' DOJ, SEC Investigations Not So Parallel Anymore

    The level of coordination between the U.S. Department of Justice and the U.S. Securities and Exchange Commission has decreased under the Trump administration, resulting in disjointed investigatory efforts and misaligned timing in parallel investigations, experts say.

  • June 04, 2026

    Supreme Court Shuts Down 'Skinny Label' Drug Patent Suit

    The U.S. Supreme Court on Thursday ended a patent suit over Hikma Pharmaceuticals USA Inc.'s generic version of a heart drug that uses a so-called skinny label, saying Amarin Pharma Inc. had not plausibly alleged that Hikma encouraged healthcare providers to infringe its patents.

  • June 04, 2026

    SEC Disgorgement Powers Stay Intact After High Court Fight

    The U.S. Supreme Court on Thursday said that the U.S. Securities and Exchange Commission could collect ill-gotten gains from alleged fraudsters without having to identify victims who were financially harmed by the fraud, declining to place further limits on the agency's disgorgement powers six years after it last did so.

  • June 03, 2026

    Campbell Soup Sued Over 'Worm-Like' Critters In SpaghettiOs

    Florida parents and their minor child have lodged a negligence suit against Campbell Soup Co. in federal court, alleging that the child and her mother discovered "worm-like organisms" moving in SpaghettiOs they ate and suffered parasitic infections as a result.

  • June 03, 2026

    AbbVie Loses Miss. Discount Drug Law Challenge For Good

    A Mississippi federal judge on Wednesday threw out a suit brought by AbbVie and other pharmaceutical manufacturers that participate in Medicaid challenging a law barring their interference with the distribution of discounted prescriptions to pharmacies serving low-income patients.

  • June 03, 2026

    House Panel Spars Over Who Benefits From Draft Privacy Bill

    The backers of a Republican-led proposal to establish a long-elusive federal data privacy standard lauded the effort during a U.S. House of Representatives hearing Wednesday for being a commonsense extension of the nearly two dozen state laws already in place, while its opponents argued that the measure would establish a weak framework that favored companies over consumers.

  • June 03, 2026

    Vista Equity Hit With Stockholder Suit Over $1.7B IAS Sale

    A former Integral Ad Science stockholder has launched a proposed class action in Delaware Chancery Court, asserting that a controlling stockholder sought the media measurement platform's $1.7 billion sale to affiliates of Novacap Management Inc. to eliminate exposure to his derivative claims alleging insider trading.

  • June 03, 2026

    Balwani Takes Theranos Conviction Challenge To Justices

    Former Theranos executive Ramesh "Sunny" Balwani is asking the U.S. Supreme Court to review his criminal fraud conviction and nearly 13-year prison sentence, arguing that the Ninth Circuit used the wrong review doctrine in rejecting his argument that prosecutors had failed to correct allegedly false testimony given by investor victims.

  • June 03, 2026

    DOJ Inks $56.5M Deal In Whistleblower Medicare Fraud Suits

    The U.S. Department of Justice said Wednesday that two health assessment companies and a founder of one of them agreed to pay $56.5 million to resolve whistleblower allegations that they submitted false diagnosis information to private Medicare insurers.

  • June 03, 2026

    'This Is Their Document': Jury Told J&J Docs Prove Talc Lies

    Counsel for the families of three women who died of ovarian cancer delivered closing arguments Wednesday in their six-week-long bellwether lawsuit against Johnson & Johnson, telling jurors that decades-old internal documents prove the company hid that its talc was contaminated with asbestos.

  • June 03, 2026

    FTC Looks For Input On X Petition To Set Aside Privacy Order

    The Federal Trade Commission is asking for the public's input on a petition from X Corp., formerly known as Twitter, to set aside or modify its 2022 $150 million settlement stemming from charges it misled users about how their data was used.

  • June 03, 2026

    Trump Moves To Bolster Customs Crackdown On Imports

    President Donald Trump signed an executive order Wednesday to strengthen Customs and Border Protection's enforcement within its existing authority by bolstering requirements for the importer of record.

  • June 03, 2026

    SDNY's Clayton Warns Of Foreign Social Media Sway

    Jay Clayton, the U.S. attorney for the Southern District of New York, warned an audience at an anti-money laundering conference Wednesday of the risk of foreign governments spending money on social media campaigns in the U.S. to "foment distrust," adding that regulators need to improve their handle on the global flow of illicit profits outside the core financial system.

  • June 03, 2026

    Tech Industry Groups Back Apple High Court Bid In Epic Case

    Several technology industry groups threw their support behind Apple Inc. on Wednesday, telling the U.S. Supreme Court an injunction issued in a case brought by Epic Games Inc. tries to alter the service Apple provides to millions of developers based on complaints from a single company.

  • June 03, 2026

    Amazon Denied Medical Accomodation, Ex-In House Atty Says

    A former in-house attorney for Amazon Web Services Inc. is accusing the company of failing to accommodate unpredictable flare-ups of her autoimmune disorder, claiming in a Washington state lawsuit that managers subjected her to a burdensome leave process that failed to respond to her medical needs.

  • June 03, 2026

    5th Circ. Says ChampionX Lacks Rights Under Spill Policy

    A Fifth Circuit panel on Tuesday affirmed a decision finding that ChampionX Corp. lacked the contractual standing to sue insurers for coverage of a $40 million oil spill lawsuit involving one of its subsidiaries, but gave the company a chance to add parties to its complaint in the lower court. 

  • June 03, 2026

    SpaceX Launches Plans For Massive $75B IPO

    SpaceX on Wednesday outlined a price target for its blockbuster initial public offering, telling U.S. regulators that it expects to raise $75 billion in what would mark the largest IPO in history.

  • June 03, 2026

    Sysco Reveals Deal Probe, Promises 'Gov't Will See Benefits'

    Sysco's CEO has disclosed that U.S. antitrust enforcers launched an in-depth probe into the wholesale restaurant food distributor's plan to acquire Jetro Restaurant Depot at a total enterprise value of approximately $29.1 billion, while expressing confidence that officials will find no issues with the transaction.

  • June 03, 2026

    Google Can't Ditch Most Chrome Privacy Claims

    A California federal judge Tuesday largely denied Google's bid to dismiss several claims in long-running litigation that accuses the tech giant of surreptitiously collecting Chrome users' personal data, after the plaintiffs elected to move forward with individual claims following their failed class certification bid.

  • June 03, 2026

    Musk's SpaceX, Tesla Emails Fair Game For Apple, OpenAI

    A Texas federal judge said X Corp. must produce Elon Musk's SpaceX and Tesla emails as part of its lawsuit accusing Apple Inc. and OpenAI of anticompetitively edging out rival artificial intelligence chatbots through a deal integrating ChatGPT into iPhones.

  • June 03, 2026

    NJ Says Most Of $3B PFAS Deal Objector Issues Are Resolved

    New Jersey told a federal court this week it has reached agreements with all but two of the parties that objected to proposed deals worth a combined $3 billion with 3M Co. and various DuPont entities to resolve claims over contamination caused by forever chemicals, saying the agreements further support the court's approval of the settlements.

  • June 03, 2026

    DOJ Sets New Healthcare Fraud Convictions Record

    The U.S. Department of Justice on Wednesday announced that its Health Care Fraud Unit secured six jury trial convictions across the country in less than three weeks, with the cases involving more than $1.1 billion in fraud losses.

  • June 03, 2026

    EU Approves BASF Buy With Conditions

    The European Commission on Monday approved the acquisition of BASF's coatings division by investment company Carlyle Group and the Qatar Investment Authority.

  • June 03, 2026

    Pillsbury Hit With Suit Over Alleged $145M Loan Fraud

    An investment fund has filed a complaint in New York State court accusing a Pillsbury Winthrop Shaw Pittman partner of conspiring with convicted fraudsters to con the fund into writing a $145 million loan to now-defunct financial services company Aspiration Partners.

Expert Analysis

  • Section 122 Tariffs Show Shift In Strategy, Not Trade Policy

    Author Photo

    By imposing temporary tariffs under Section 122 of the Trade Act as a stopgap measure while it pivots to less transitory statutory authorities, the Trump administration sent a clear message that the U.S. Supreme Court’s decision in Learning Resources v. Trump, invalidating duties imposed under the International Emergency Economic Powers Act, will not precipitate a change in policy direction, say attorneys at Snell & Wilmer.

  • Series

    Podcasting Makes Me A Better Lawyer

    Author Photo

    Podcasting has changed how I ask questions and connect with people, sharpening my ability to listen without interrupting or prejudging, and bringing me closer to what law is meant to be: a human profession grounded in understanding, judgment and trust, says Donna DiMaggio Berger at Becker.

  • AG Watch: Ohio Targets DEI Policies

    Author Photo

    As Ohio Attorney General Dave Yost seeks to eliminate diversity, equity and inclusion programs in both public education institutions and private companies, Ohio entities must carefully navigate this constantly evolving, highly contentious topic to avoid litigation while also not forfeiting their core principles, say attorneys at BakerHostetler.

  • Del. Coinbase Outcome May Have Been Different In Texas

    Author Photo

    The Delaware Court of Chancery's recent decision in Grabski v. Andreessen, finding that a member of the Coinbase special litigation committee was not independent, provides guidance for Delaware boards regarding the formation, composition and operation of SLCs, while offering a counterpoint to the procedures available to Texas-incorporated companies, says John Lawrence at Baker Botts.

  • Why The NCUA's Stablecoin Moment Matters

    Author Photo

    The National Credit Union Administration, a historically conservative federal agency, recently proposed a detailed stablecoin licensing framework, confirming that the proposition of building a regulatory architecture within the banking industry has moved well past "whether" and firmly into "how," says Stephen Aschettino at Fox Rothschild.

  • Lessons From Justices' Split On Major Questions Doctrine

    Author Photo

    The justices' varied opinions in Learning Resources v. Trump, which held the International Emergency Economy Powers Act did not confer the power to impose tariffs, offer a meaningful window into the U.S. Supreme Court's perspective on the major questions doctrine that will likely shape lower courts' approach to executive action challenges, say attorneys at Venable.

  • Drug Wholesaler's DPA Shows Imperfect Efforts Still Count

    Author Photo

    Atlantic Biologicals’ recent deferred prosecution agreement with federal prosecutors for allegedly distributing controlled substances to pill mill pharmacies demonstrates that even subpar cooperation, when combined with genuine remediation and strategic advocacy, can yield outcomes that protect a company's long-term interests, says Jonathan Porter at Husch Blackwell.

  • Share Repurchases Leave Cos. Susceptible To Litigation

    Author Photo

    Because share repurchases bring greater ownership, which typically brings greater voting power, they can have serious implications for corporate control, which can raise questions about the unpaid benefits to some shareholders and lead to securities class actions, says Amit Bubna at Bates White.

  • How The New Tariff Landscape May Unfold

    Author Photo

    To replace tariffs formerly imposed under the International Emergency Economic Powers Act, the administration will rely on a patchwork of statutes, potentially leading to procedural challenges and a complex tariff landscape with varying levels, durations and applicability, says Joseph Grossman-Trawick at King & Spalding.

  • How DOJ Is Rethinking Corporate Crime Prosecution Tactics

    Author Photo

    Recent statements from the Justice Department seem to indicate an incremental shift away from relying on collective employee knowledge when prosecuting corporate crime, and from exploring the bounds of case law that has not been a model of clarity, say attorneys at Covington.

  • Del. Justices' Upholding Of SB 21 Gives Cos. Needed Clarity

    Author Photo

    The Delaware Supreme Court's recent unanimous decision in Rutledge v. Clearway Energy — upholding 2025 corporate law amendments enacted through S.B. 21, which clarified safe harbor protections and key terms — may help stem the DExit movement, whose proponents have claimed unpredictability in Delaware courts, say attorneys at Nelson Mullins.

  • Unique Issues Facing Brand-Compounder Patent Litigation

    Author Photo

    Recent litigation and potential enforcement action against Hims & Hers Health raise questions about how compounders and branded pharmaceuticals companies would be positioned in patent litigation as compared to generics companies, which would require strategies different from those that would be used in traditional Hatch-Waxman Act litigation, say attorneys at Morgan Lewis.

  • How Banks Can Apply FinCEN Beneficial Ownership Relief

    Author Photo

    A recent Financial Crimes Enforcement Unit order limiting the circumstances under which banks should identify and verify beneficial owners may allow banks to tailor their approach to verification compliance, but only after reviewing customer due diligence policies and evaluating alignment with their risk profiles, say attorneys at Cleary.

  • Series

    Volunteering With Scouts Makes Me A Better Lawyer

    Author Photo

    Serving as an assistant scoutmaster for my son’s troop reaffirmed several skills and principles crucial to lawyering — from the importance of disconnecting to the value of morality, says Michael Warren at McManis Faulkner.

  • AI Communications May Be Discoverable In Patent Litigation

    Author Photo

    A New York federal court's recent determination that a defendant's correspondence with an artificial intelligence tool was not protected by attorney-client privilege may have significant ramifications for patent matters, highlighting the risk of AI use in patent prosecution and litigation tasks, say attorneys at Seed IP.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Corporate archive.